跳至主要内容
临床试验/NCT03917498
NCT03917498进行中(未招募)不适用

Single Pre-Operative Radiation Therapy - With Delayed Surgery (SPORT-DS) for Low Risk Breast Cancer: A Phase 1 Study

Michael Yassa1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2018年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Michael Yassa
入组人数
20
试验地点
1
主要终点
rate of pathological complete response

研究概览

简要总结

To study a single dose of preoperative partial radiotherapy to a low-risk breast tumour. The radiotherapy will be goven 3 months before surgery.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
Female
接受健康志愿者
是

入选标准

  • •Female aged 65 years or older
  • •World Health Organization (WHO) performance status 0-2
  • •Invasive ductal carcinoma proven by biopsy done ≤ 12 weeks from treatment start
  • •Unifocal disease on preoperative staging ultrasound done ≤ 12 weeks from treatment start
  • •Tumors less than 2cm clinically on physical exam, as well as on breast ultrasound
  • •No clinical evidence of nodal disease (i.e. cN0), on physical examination done ≤ 12 weeks from treatment start, as well as on breast ultrasound
  • •Estrogen receptor status (ER) positive on biopsy
  • •Her2 negative on biopsy
  • •Grade 1 or 2 on biopsy
  • •Planned surgery is a partial mastectomy with sentinel lymph node biopsy
  • •Localisation markers placed before treatment

排除标准

  • •Age less than 65 years
  • •A known deleterious mutation in BRCA 1 and/or BRCA 2
  • •Clinical tumor size > 2.0 cm in greatest diameter on staging ultrasound
  • •Tumor histology limited to lobular carcinoma only
  • •Clinically positive axillary nodes (cN+)
  • •Lymphovascular invasion on biopsy
  • •Pure ductal or lobular carcinoma in situ on biopsy
  • •Extensive intraductal component on biopsy
  • •Neoadjuvant hormonal manipulation or chemotherapy
  • •Prior history of cancer (Patients with prior or concurrent basal cell or squamous cell skin cancers are eligible for the trial)
  • •More than one primary tumor in different quadrants of the same breast
  • •Diffuse microcalcifications on mammography
  • •Paget's disease of the nipple
  • •Previous irradiation to the ipsilateral breast
  • •Presence of an ipsilateral breast implant or pacemaker
  • •Serious non-malignant disease (e.g. cardiovascular, pulmonary, systemic lupus erythematosus (SLE), scleroderma) which would preclude definitive radiation treatment
  • •Estrogen receptor status (ER) not known
  • •Currently pregnant or lactating
  • •Psychiatric or addictive disorders which would preclude obtaining informed consent or adherence to protocol
  • •Geographic inaccessibility for follow-up
  • •Lack of preoperative staging with breast and axillary ultrasound
  • •Inability to adequately plan the patient for the experimental technique

研究组 & 干预措施

Single Pre-Operative Radiation Therapy with Delayed Surgery

Experimental

Single Pre-Operative Radiation Therapy with Delayed Surgery

干预措施: Single Pre-Operative Radiation Therapy - with Delayed Surgery (Radiation)

结局指标

主要结局

rate of pathological complete response

时间窗: at the time of surgery

次要结局

  • incidence of radiation toxicity(in the 2 years after treatment)

研究者

发起方
Michael Yassa
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Michael Yassa

Radiation Oncologist

Maisonneuve-Rosemont Hospital

研究点 (1)

Loading locations...

相似试验

Single Pre-Operative Radiation Therapy - With... | 临床试验